KATY FLOWERS: Open Payments
NPI 1194274878 · JAMESTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,624 in 98 payments from 22 companies in 2025. Trend: 2023 $1,700 · 2024 $1,963 · 2025 $1,624
Food & beverage: $1,624
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $200 |
| ABBVIE INC. | 15 | $195 |
| Lilly USA, LLC | 10 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $159 |
| Amgen Inc. | 10 | $138 |
| Corcept Therapeutics | 5 | $106 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| PFIZER INC. | 4 | $83 |
| Exact Sciences Corporation | 4 | $70 |
| Phathom Pharmaceuticals, Inc. | 5 | $63 |
Products named: MOUNJARO, CAPLYTA, OTEZLA, VRAYLAR, Korlym, Ozempic, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across TN — which companies pay providers there.
